A guide to assessing cellular senescence in vitro and in vivo
Cellular senescence is a physiological mechanism whereby a proliferating cell undergoes a
stable cell cycle arrest upon damage or stress and elicits a secretory phenotype. This highly …
stable cell cycle arrest upon damage or stress and elicits a secretory phenotype. This highly …
[HTML][HTML] Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics
Y Han, SY Kim - Experimental & Molecular Medicine, 2023 - nature.com
Senescence compromises the essential role that the endothelium plays in maintaining
vascular homeostasis, so promoting endothelial dysfunction and the development of age …
vascular homeostasis, so promoting endothelial dysfunction and the development of age …
[HTML][HTML] Mechanisms of sensitivity and resistance to CDK4/6 inhibition
M Álvarez-Fernández, M Malumbres - Cancer cell, 2020 - cell.com
Inhibiting the cell-cycle kinases CDK4 and CDK6 results in significant therapeutic effect in
patients with advanced hormone-positive breast cancer. The efficacy of this strategy is …
patients with advanced hormone-positive breast cancer. The efficacy of this strategy is …
CDK4/6 inhibition in cancer: beyond cell cycle arrest
S Goel, MJ DeCristo, SS McAllister, JJ Zhao - Trends in cell biology, 2018 - cell.com
Pharmacologic inhibitors of cyclin-dependent kinases 4 and 6 (CDK4/6) have recently
entered the therapeutic armamentarium of clinical oncologists, and show promising activity …
entered the therapeutic armamentarium of clinical oncologists, and show promising activity …
[HTML][HTML] Ageing, cellular senescence and neurodegenerative disease
M Kritsilis, S V. Rizou, PN Koutsoudaki… - International journal of …, 2018 - mdpi.com
Ageing is a major risk factor for developing many neurodegenerative diseases. Cellular
senescence is a homeostatic biological process that has a key role in driving ageing. There …
senescence is a homeostatic biological process that has a key role in driving ageing. There …
Treating cancer with selective CDK4/6 inhibitors
B O'leary, RS Finn, NC Turner - Nature reviews Clinical oncology, 2016 - nature.com
Uncontrolled cellular proliferation, mediated by dysregulation of the cell-cycle machinery
and activation of cyclin-dependent kinases (CDKs) to promote cell-cycle progression, lies at …
and activation of cyclin-dependent kinases (CDKs) to promote cell-cycle progression, lies at …
[HTML][HTML] Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network - Nature, 2014 - ncbi.nlm.nih.gov
Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report
molecular profiling of 230 resected lung adenocarcinomas using messenger RNA …
molecular profiling of 230 resected lung adenocarcinomas using messenger RNA …
Forging a signature of in vivo senescence
NE Sharpless, CJ Sherr - Nature Reviews Cancer, 2015 - nature.com
Abstract'Cellular senescence', a term originally defining the characteristics of cultured cells
that exceed their replicative limit, has been broadened to describe durable states of …
that exceed their replicative limit, has been broadened to describe durable states of …
The CDK4/6 inhibitor revolution—A game-changing era for breast cancer treatment
L Morrison, S Loibl, NC Turner - Nature Reviews Clinical Oncology, 2024 - nature.com
Abstract Cyclin-dependent kinase (CDK) 4/6 inhibition in combination with endocrine
therapy is the standard-of-care treatment for patients with advanced-stage hormone receptor …
therapy is the standard-of-care treatment for patients with advanced-stage hormone receptor …
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report
molecular profiling of 230 resected lung adenocarcinomas using messenger RNA …
molecular profiling of 230 resected lung adenocarcinomas using messenger RNA …